Literature DB >> 17707176

Genetic testing in cardiovascular disease.

Nathaniel H Robin1, Paul B Tabereaux, Raymond Benza, Bruce R Korf.   

Abstract

Genetic testing is increasingly becoming possible for diagnosis, susceptibility testing, and prognostication in cardiovascular medicine. The practicing cardiologist, therefore, needs to be familiar with the clinical utilities and limitations of genetic testing. This review explores the major approaches to genetic testing and issues in test interpretation. Specific applications to cardiovascular diseases, including coronary artery disease, cardiomyopathies, cardiac arrhythmias, and pulmonary arterial hypertension are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17707176     DOI: 10.1016/j.jacc.2007.05.015

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

Review 1.  Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity.

Authors:  M Schwartz; J Kipnis
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

Review 2.  Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Karl V Voelkerding; Shale Dames; Jacob D Durtschi
Journal:  J Mol Diagn       Date:  2010-09       Impact factor: 5.568

Review 3.  Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors:  Ray E Hershberger
Journal:  J Cardiovasc Transl Res       Date:  2008-05-20       Impact factor: 4.132

Review 4.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

Review 5.  Cardiovascular genomics: a biomarker identification pipeline.

Authors:  John H Phan; Chang F Quo; May Dongmei Wang
Journal:  IEEE Trans Inf Technol Biomed       Date:  2012-05-16

Review 6.  [Noncompaction cardiomyopathy].

Authors:  J Shariati; T Schlosser; R Erbel
Journal:  Herz       Date:  2015-06       Impact factor: 1.443

7.  ALOX5AP gene variants show differential association with coronary artery disease in different populations.

Authors:  Ahmad Alwan; Sonia C Youhanna; Daniel E Platt; Mirvat El-Sibai; Joumana S Yerezian; Mary E Deeb; Georges Khazen; Stephanie Saadé; Tony G Zreik; Hamid El Bayeh; Assaad Maalouf; Antoine Abchee; Pierre A Zalloua
Journal:  J Community Genet       Date:  2010-08-18

Review 8.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

9.  Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.

Authors:  Katharine M Brauch; Margaret L Karst; Kathleen J Herron; Mariza de Andrade; Patricia A Pellikka; Richard J Rodeheffer; Virginia V Michels; Timothy M Olson
Journal:  J Am Coll Cardiol       Date:  2009-09-01       Impact factor: 24.094

Review 10.  The family history: reemergence of an established tool.

Authors:  Robert B Hinton
Journal:  Crit Care Nurs Clin North Am       Date:  2008-06       Impact factor: 1.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.